⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11453507 | 1.00 | GAA (0.33) | — | |
| SCHEMBL1903715 | 0.82 | — | — | |
| SCHEMBL24990103 | 0.80 | SLC6A9 (0.33) | — | |
| SCHEMBL13132319 | 0.80 | SIGMAR1 (0.33) | — | |
| SCHEMBL12337451 | 0.80 | SIGMAR1 (0.33) | — | |
| SCHEMBL9660811 | 0.77 | — | — | |
| SCHEMBL11529742 | 0.77 | — | — | |
| SCHEMBL23366040 | 0.77 | ALDH1A1 (0.33) | — | |
| SCHEMBL11992646 | 0.76 | — | — | |
| SCHEMBL13627394 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020263888-A1 | CANNABINOID CONJUGATE MOLECULES | DIVERSE BIOTECH, INC. (US) | 2020-12-30 | — | — | WO | disclosed |
| US-10632171-B2 | Melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2020-04-28 | — | — | US | disclosed |
| US-20140220047-A1 | MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS | SEATTLE GENETICS, INC. (US) | 2014-08-07 | — | — | US | disclosed |
| US-20120225828-A1 | Melanocortin-1 Receptor-Specific Cyclic Peptides | PALATIN TECHNOLOGIES, INC. (US) | 2012-09-06 | — | — | US | disclosed |
| US-20120225831-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES, INC. (US) | 2012-09-06 | — | — | US | disclosed |
| US-20120178701-A1 | Melanocortin Receptor-Specific Peptides | PALATIN TECHNOLOGIES, INC. (US) | 2012-07-12 | — | — | US | disclosed |
| US-20100160287-A1 | COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-06-24 | — | — | US | disclosed |
| WO-2008046232-A1 | AZIRIDINE ALDEHYDES, AZIRIDINE-CONJUGATED AMINO DERIVATIVES, AZIRIDINE-CONJUGATED BIOMOLECULES AND PROCESSES FOR THEIR PREPARATION | YUDIN ANDREI K (CA) | 2008-04-24 | — | — | WO | disclosed |
| WO-2001012599-A1 | NEW ETHYLAZIRIDINE DERIVATIVES AND THEIR PREPARATION METHODS | SAMCHULLY PHARM CO., LTD. (KR) | 2001-02-22 | — | — | WO | disclosed |
| EP-0220988-B1 | PROCESS FOR CULTURING BABESIA CANIS, USE IN THE PREPARATION OF ANTIGENS AND VACCINES, AND ANTIGENS AND VACCINES AGAINST PIROPLASMOSIS | RHONE MERIEUX (FR) | 1990-05-30 | — | — | EP | disclosed |
| EP-0220988-A1 | Process for culturing Babesia canis, use in the preparation of antigens and vaccines, and antigens and vaccines against piroplasmosis | RHONE MERIEUX (FR) | 1987-05-06 | — | — | EP | disclosed |